AGT and hypertensive disorder: SHR are known to have a very high level of angiotensin II expression and downstream AT1 receptor activation for the induction of high blood pressure (Mao and Li, 2015) and hence AT1 receptor blockers were found to be the most frequently reported antihypertensive agent in these models (Choisy et al., 2015).